Robert Redfield's Insider Trades & SAST Disclosures

Robert Redfield's most recent trade in Traws Pharma Inc. was a trade of 97,500 Common Stock done . Disclosure was reported to the exchange on April 1, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Traws Pharma Inc.
Robert Redfield Acting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 97,500 97,500 (0%) 0% - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades